Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT02770664
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT02770664
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- Not reported
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT02770664. Randomized; double masking; primary purpose treatment. Start 2016-04 (registry gives no type); primary completion 2018-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients
- Condition
- ST-segment Elevation Myocardial Infarction
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- LC28-0126 Dose A
- Intervention (Drug)
- LC28-0126 Dose B
- Intervention (Drug)
- LC28-0126 Dose C
- Lead sponsor
- LG Life Sciences
Record details
- Record id
cardio:ct-nct02770664- Content hash
6c06622b8498ce4e2e7f0372daf97b2e0657c6ae8f0fa9e849250765b0848ef3